Collection from MedEngine

Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis

Payvandi et al. Blood Advances; 2021, 5(8): 2137-2141

Select your desired language:

Supplementary material to accompany "Caplacizumab prevents refractoriness and mortality in acquired thrombotic thrombocytopenic purpura: integrated analysis"

Payvandi et al. Blood Advances; 2021, 5(8): 2137-2141
Content © 2021 by The American Society of Hematology